In accordance with the Food and Drug Administration's "Administrative Directive Based on the Results of the 2011 Drug Literature Re-evaluation" (Drug Management Division-No. 6843, effective date 2012.12.31), the efficacy, dosage, and precautions for use of 26 products including Xanitin tablets have been changed.
For further details, please refer to the latest information uploaded in the change information section of the ‘Product Introduction’ section.
(Main information, overall information, medication guidance, and manual download items will be applied sequentially.)